{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T21:51:51Z","timestamp":1768513911939,"version":"3.49.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ejpb.2024.114604","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T16:41:51Z","timestamp":1734108111000},"page":"114604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Human milk improves the oral bioavailability of the poorly water-soluble drug clofazimine"],"prefix":"10.1016","volume":"207","author":[{"given":"Ellie","family":"Ponsonby-Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna C.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3676-4647","authenticated-orcid":false,"given":"Shouyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malinda","family":"Salim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7287-8029","authenticated-orcid":false,"given":"Laura D.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5123-695X","authenticated-orcid":false,"given":"Simone Margaard","family":"Offersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Thymann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5434-590X","authenticated-orcid":false,"given":"Ben J.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejpb.2024.114604_b0005","article-title":"Promoting appropriate use of drugs in children","volume":"2012","author":"Yewale","year":"2012","journal-title":"Int. J. Pediatr."},{"key":"10.1016\/j.ejpb.2024.114604_b0010","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2147\/IJGM.S280330","article-title":"Safety and biopharmaceutical challenges of excipients in off-label pediatric formulations","volume":"13","author":"Belayneh","year":"2020","journal-title":"Int. J. Gen. Med."},{"issue":"9","key":"10.1016\/j.ejpb.2024.114604_b0015","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.3390\/biomedicines10092055","article-title":"Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics","volume":"10","author":"Bhalani","year":"2022","journal-title":"Biomedicines."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114604_b0020","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijpharm.2015.03.023","article-title":"Characterising the disintegration properties of tablets in opaque media using texture analysis","volume":"486","author":"Scheuerle","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114604_b0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2018.10.069","article-title":"Revisiting dispersible milk-drug tablets as a solid lipid formulation in the context of digestion","volume":"554","author":"Binte Abu Bakar","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114604_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114139","article-title":"Opportunities for milk and milk-related systems as 'new' low-cost excipient drug delivery materials","volume":"183","author":"Salim","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2024.114604_b0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jconrel.2023.08.037","article-title":"Evaluating human milk as a drug delivery vehicle for clofazimine to premature infants","volume":"362","author":"Ponsonby-Thomas","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2024.114604_b0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jconrel.2018.10.027","article-title":"The impact of digestion is essential to the understanding of milk as a drug delivery system for poorly water soluble drugs","volume":"292","author":"Boyd","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2024.114604_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124257","article-title":"Infant formula as a solid lipid dose form for enhancement of the oral bioavailability of cannabidiol for paediatric patients","volume":"660","author":"Huang","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.ejpb.2024.114604_b0050","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1021\/acs.molpharmaceut.8b00541","article-title":"Interactions of artefenomel (OZ439) with milk during digestion: insights into digestion-driven solubilization and polymorphic transformations","volume":"15","author":"Salim","year":"2018","journal-title":"Mol. Pharm."},{"issue":"10","key":"10.1016\/j.ejpb.2024.114604_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14102228","article-title":"Revisiting the dissolution of praziquantel in biorelevant media and the impact of digestion of milk on drug dissolution","volume":"14","author":"Eason","year":"2022","journal-title":"Pharmaceutics"},{"issue":"9832","key":"10.1016\/j.ejpb.2024.114604_b0060","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S0140-6736(12)60560-1","article-title":"Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000","volume":"379","author":"Liu","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejpb.2024.114604_b0065","doi-asserted-by":"crossref","unstructured":"Clofazimine. Tuberculosis. 2008;88(2):96-9.","DOI":"10.1016\/S1472-9792(08)70006-4"},{"issue":"1","key":"10.1016\/j.ejpb.2024.114604_b0070","first-page":"e00794","article-title":"Pharmacokinetics and cardiac safety of clofazimine in children with rifampicin-resistant tuberculosis","volume":"68","author":"Ali Ali","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114604_b0075","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jppr.1893","article-title":"Stability of extemporaneously prepared clofazimine oral suspensions","volume":"54","author":"Ponsonby-Thomas","year":"2024","journal-title":"J. Pharm. Pract. Res."},{"issue":"6","key":"10.1016\/j.ejpb.2024.114604_b0080","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1021\/acs.molpharmaceut.9b00276","article-title":"Solid-state behavior and solubilization of flash nanoprecipitated clofazimine particles during the dispersion and digestion of milk-based formulations","volume":"16","author":"Salim","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2024.114604_b0085","article-title":"Prenatal gastrointestinal development in the pig and responses after preterm birth","volume":"90(suppl_4):290\u20138","author":"Buddington","year":"2012","journal-title":"J. Anim. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114604_b0090","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114604_b0095","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/s13346-020-00851-z","article-title":"Sustained absorption of delamanid from lipid-based formulations as a path to reduced frequency of administration","volume":"11","author":"Ramirez","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"issue":"6","key":"10.1016\/j.ejpb.2024.114604_b0100","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202300458","article-title":"A gently processed skim milk-derived whey protein concentrate for infant formula: effects on gut development and immunity in preterm pigs","volume":"68","author":"Aasmul-Olsen","year":"2024","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.ejpb.2024.114604_b0105","unstructured":"Organisation WH. Notes on the Design of Bioequivalence Study: Clofazimine. WHO\/PQT: medicines 2021."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114604_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vascn.2012.10.004","article-title":"The impact of the site of blood sampling on pharmacokinetic parameters following sublingual dosing to dogs","volume":"67","author":"Sohlberg","year":"2013","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejpb.2024.114604_b0115","first-page":"3","article-title":"Safety of cow\u2019s milk-derived fortifiers used with an all-human milk base diet in very low birthweight preterm infants","volume":"15","author":"Lucas","year":"2020","journal-title":"Neonatology Today"},{"issue":"30","key":"10.1016\/j.ejpb.2024.114604_b0120","doi-asserted-by":"crossref","first-page":"35847","DOI":"10.1021\/acsami.3c05012","article-title":"Construction of a synthetic colostrum substitute and its protection of intestinal cells against inflammation in an in vitro model of necrotizing enterocolitis","volume":"15","author":"Binte Abu Bakar","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"4","key":"10.1016\/j.ejpb.2024.114604_b0125","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/ajcn\/63.4.546","article-title":"Gastrojejunal kinetics and the digestion of [15N]beta-lactoglobulin and casein in humans: the influence of the nature and quantity of the protein","volume":"63","author":"Mah\u00e9","year":"1996","journal-title":"Am. J. Clin. Nutr."},{"issue":"5","key":"10.1016\/j.ejpb.2024.114604_b0130","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1021\/acsabm.0c00131","article-title":"Correlating digestion-driven self-assembly in milk and infant formulas with changes in lipid composition","volume":"3","author":"Pham","year":"2020","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.ejpb.2024.114604_b0135","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tube.2004.04.001","article-title":"Pharmacokinetics and relative bioavailability of clofazimine in relation to food, orange juice and antacid","volume":"84","author":"Nix","year":"2004","journal-title":"Tuberculosis (Edinb.)"},{"issue":"1","key":"10.1016\/j.ejpb.2024.114604_b0140","first-page":"9","article-title":"Pharmacokinetics of clofazimine in healthy volunteers","volume":"55","author":"Schaad-Lanyi","year":"1987","journal-title":"Int. J. Lepr. Other Mycobact. Dis."},{"key":"10.1016\/j.ejpb.2024.114604_b0145","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejpb.2023.04.009","article-title":"Improvement and characterization of oral absorption behavior of clofazimine by SNEDDS: Quantitative evaluation of extensive lymphatic transport","volume":"187","author":"Yamanouchi","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114604_b0150","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/03639045.2021.1892743","article-title":"Nanostructured lipid carrier-mediated lung targeted drug delivery system to enhance the safety and bioavailability of clofazimine","volume":"47","author":"Patil","year":"2021","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2024.114604_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113993","article-title":"Metabolism and interactions of antileprosy drugs","volume":"177","author":"George","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejpb.2024.114604_b0160","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1128\/AAC.00260-15","article-title":"Pharmacokinetics and pharmacodynamics of clofazimine in a mouse model of tuberculosis","volume":"59","author":"Swanson Rosemary","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114604_b0165","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01560-21","article-title":"Pharmacokinetics and pharmacodynamics of clofazimine for treatment of cryptosporidiosis","volume":"66","author":"Zhang","year":"2022","journal-title":"Antimicrob Agents Chemother."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114604_b0170","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/bdd.2510150407","article-title":"Comparative bioavailability of clofazimine coevaporate in the pig","volume":"15","author":"Krishnan","year":"1994","journal-title":"Biopharm Drug Dispos."},{"key":"10.1016\/j.ejpb.2024.114604_b0175","series-title":"Oral drug absorption in pediatric populations","first-page":"108","author":"Edginton","year":"2010"},{"key":"10.1016\/j.ejpb.2024.114604_b0180","series-title":"Pediatric Formulations: A Roadmap","first-page":"43","article-title":"Paediatric Development: Gastrointestinal","author":"Batchelor","year":"2014"},{"issue":"3","key":"10.1016\/j.ejpb.2024.114604_b0185","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/bcp.12267","article-title":"Paediatric pharmacokinetics: key considerations","volume":"79","author":"Batchelor","year":"2015","journal-title":"Br J Clin Pharmacol."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114604_b0190","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/jphp.12912","article-title":"The pig as a preclinical model for predicting oral bioavailability and invivo performance of pharmaceutical oral dosage forms: a PEARRL review","volume":"71","author":"Henze","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114604_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13010044","article-title":"The neonatal and juvenile pig in pediatric drug discovery and development","volume":"13","author":"Ayuso","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2024.114604_b0200","first-page":"327","article-title":"Preparation of sulindac with skimmed milk via freeze-drying","volume":"53","author":"Topaloglu","year":"1998","journal-title":"Pharmazie"},{"issue":"10","key":"10.1016\/j.ejpb.2024.114604_b0205","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0014-827X(99)00065-8","article-title":"Inclusion of ketoprofen with skimmed milk by freeze-drying","volume":"54","author":"Topalo\u011flu","year":"1999","journal-title":"Il Farmaco."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114604_b0210","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1021\/acs.molpharmaceut.9b01149","article-title":"Low-frequency Raman scattering spectroscopy as an accessible approach to understand drug solubilization in milk-based formulations during digestion","volume":"17","author":"Salim","year":"2020","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114604_b0215","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijpharm.2010.01.038","article-title":"Novel milk-based oral formulations: proof of concept","volume":"390","author":"Charkoftaki","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/j.ejpb.2024.114604_b0220","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/jps.2600750716","article-title":"Studies on drug\u2014milk freeze-dried formulations i: bioavailability of sulfamethizole and dicumarol formulations","volume":"75","author":"Macheras","year":"1986","journal-title":"J. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.ejpb.2024.114604_b0225","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jps.2600751206","article-title":"Studies on freeze-dried drug-milk formulations II: effect of regenerated fluid volume on nitrofurantoin bioavailability","volume":"75","author":"MacHeras","year":"1986","journal-title":"J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2024.114604_b0230","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ijpharm.2015.05.015","article-title":"Milk as a medium for pediatric formulations: Experimental findings and regulatory aspects","volume":"492","author":"Soulele","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114604_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2020.103502","article-title":"Incredible pharmaceutical residues in human milk in a cohort study from \u015eanl\u0131urfa in Turkey","volume":"80","author":"Yal\u00e7in","year":"2020","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114604_b0240","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijpharm.2012.05.035","article-title":"A nipple shield delivery system for oral drug delivery to breastfeeding infants: Microbicide delivery to inactivate HIV","volume":"434","author":"Gerrard","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114604_b0245","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijpharm.2017.12.042","article-title":"Zinc delivery from non-woven fibres within a therapeutic nipple shield","volume":"537","author":"Maier","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114604_b0250","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejps.2019.01.032","article-title":"Iron delivery from liquid-core hydrogels within a therapeutic nipple shield","volume":"131","author":"Maier","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114604_b0255","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1542\/peds.2011-0204","article-title":"The prevalence, severity, and distribution of childhood food allergy in the United States","volume":"128","author":"Gupta","year":"2011","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.ejpb.2024.114604_b0260","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3390\/pharmaceutics14071342","article-title":"Milk oral lyophilizates with loratadine: screening for new excipients for pediatric use","volume":"14","author":"Iurian","year":"2022","journal-title":"Pharmaceutics"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124004302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124004302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T19:43:00Z","timestamp":1738438980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641124004302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":52,"alternative-id":["S0939641124004302"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114604","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human milk improves the oral bioavailability of the poorly water-soluble drug clofazimine","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114604","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114604"}}